Most modern weight loss injections belong to a drug class called GLP-1 receptor agonists
based on strategic pipeline considerations (NCT05517226), although it is still ongoing in the EU (2021-005484-53)
It also supports compliance with regulatory guidelines such as ICH, FDA, and EMA
Whether youre interested in how to microdose GLP-1 for perimenopause, autoimmune support, or general metabolic optimization, our providers can help determine the right approach for you
Whether you plan to stay on a maintenance dose, taper off completely, or cycle on and off, the habits you build during treatment determine your long-term outcome
Also, the combination strategy is classified as either an add-on therapy or a simultaneous initiation of both medications